Astrea Bioseparations - About the company
Astrea Bioseparations is an acquired company based in Cambridge (United Kingdom), founded in 1987. It operates as a Provider of purification and separation tools for the development of therapeutics. The company has 785 active competitors, including 48 funded and 94 that have exited. Its top competitors include companies like Abcam, Enzo and Meridian Bioscience.
Company Details
Provider of purification and separation tools for the development of therapeutics. It offers Nereus LentiHERO lentiviral vector purification technology for cell and gene therapy development and manufacturing.
- Website
- astreabioseparations.com
- Social
- Phone Number
- +44 **********
- Registered Address
- UNIT 1A BARTON ROAD,COMBERTON,CAMBRIDGE,CB23 7AJ
Key Metrics
Founded Year
1987
Location
Cambridge, United Kingdom
Stage
Acquired
Ranked
76th among 785 active competitors
Employee Count
130 as on Jul 31, 2026
Investment & Acquisitions
Exit Details
Acquired by Biotage (Feb 28, 2023)
Legal entities associated with Astrea Bioseparations
Astrea Bioseparations is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
ASTREA BIOSEPARATIONS LTD. CIN: 2149359 , United Kingdom, Active | Jul 21, 1987 | - | - | |
ASTREA UK SERVICES LIMITED CIN: 12559260 , United Kingdom, Active | Apr 15, 2020 | - | 64 (As on Jan 31, 2022) | |
ASTREA BIOSEPARATIONS LTD CIN: OE027213 , United Kingdom, Active | Feb 20, 2023 | - | - |
Astrea Bioseparations's acquisition details
Click here to take a look at Astrea Bioseparations's acquisition in detail
Sign up to download Astrea Bioseparations' company profile
Astrea Bioseparations's funding and investors
Astrea Bioseparations has not raised any funding rounds yet.
Astrea Bioseparations' founders and board of directors
Founder? Claim ProfileAstrea Bioseparations' employee count trend
Astrea Bioseparations has 130 employees as of Jul 26. Here is Astrea Bioseparations's employee count trend over the years:
Uncover Astrea Bioseparations' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Astrea Bioseparations's Competitors and alternates
Top competitors of Astrea Bioseparations include Abcam, Enzo and Meridian Bioscience. Here is the list of Top 10 competitors of Astrea Bioseparations, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Abcam 1998, Cambridge (United Kingdom), Acquired | Developer of biological reagents for life science research | $78.8M | 76/100 | |
2nd | Enzo 1976, Farmingdale (United States), Acquired | Life science products and services for research, drug discovery, and manufacturing | $7M | - | 65/100 |
3rd | Meridian Bioscience 1976, Ohio (United States), Acquired | Molecular diagnostic device and kits | - | 65/100 | |
4th | Firefly BioWorks 2009, Cambridge (United States), Acquired | Develops platform to allow multiplexed assays on standard laboratory instrumentation | $3.77M | 59/100 | |
5th |  Huwel Life 2015, Hyderabad (India), Series A | Molecular diagnostic solutions and products for the healthcare industry | $5.74M | 59/100 | |
6th | Stem Cell Technologies 1993, Vancouver (Canada), Series A | Developer of cell culture media and ancillary reagents for life science research | $11.9M | 58/100 | |
7th | Cell culture reagents for stem cell research | $18.2M | 56/100 | ||
8th | Teknova 1996, Hollister (United States), Public | Provider of molecular biology research reagents and kits | - | 55/100 | |
9th | Luminex 1995, Austin (United States), Acquired | Developer of instruments, reagents and kits for clinical diagnostics and life science research | - | 55/100 | |
10th | PL BioScience 2015, Aachen (Germany), Series A | Manufacturer of human platelet lysate products for cell culture applications | $13M | 55/100 | |
76th |  Astrea Bioseparations 1987, Cambridge (United Kingdom), Acquired | Provider of purification and separation tools for the development of therapeutics | - | - | 35/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Astrea Bioseparations's competitors? Click here to see the top ones
Astrea Bioseparations's Investments and acquisitions
Astrea Bioseparations has acquired Delta Precision. Astrea Bioseparations has not made any investments as of now.Reports related to Astrea Bioseparations
Here is the latest report on Astrea Bioseparations's sector:
News related to Astrea Bioseparations
Filter this list•
4basebio names Gabe Longoria as new chief commercial officerMorningstar•Jan 08, 2025•4basebio, Astrea Bioseparations
•
•
Biotage’s USD 215 Million Acquisition of Astrea BioseparationsGlobal Legal Chronicle•Feb 28, 2023•Biotage, Astrea Bioseparations
•
•
•
•
Astrea Bioseparations makes critical infrastructure investments in Cambridge, UK and SingaporeBioSpectrum Asia•Sep 18, 2021•Astrea Bioseparations
•
Gamma Biosciences Names Terry Pizzie as CEO of Astrea BioseparationsBioSpectrum Asia•Jun 14, 2021•Gamma Biosciences, Astrea Bioseparations, Horizon Discovery
•
Gamma Biosciences ties up with Astrea BioseparationsIndiaMedToday•Dec 22, 2020•Gamma Biosciences, Astrea Bioseparations
•
Avacta Group license agreement with Astrea Bioseparations for affinity purification applicationsDirectorsTalk Interviews•Dec 21, 2020•Avacta, Astrea Bioseparations
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Astrea Bioseparations
Explore our recently published companies
- Gnork - Unfunded company
- Sunshine Doors Specialists - United States based, 2000 founded, Unfunded company
- Profila Coscare - Virar based, 2021 founded, Unfunded company
- Hive Tech - Pune based, 2024 founded, Unfunded company
- Konzap Media - Estonia based, Unfunded company
- Seqventia - Croatia based, 2017 founded, Unfunded company
